Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Résultat de la recherche
5 recherche sur le mot-clé 'Marijuana'
Affiner la recherche Générer le flux rss de la recherche
Partager le résultat de cette recherche Faire une suggestion
Childhood polyvictimization and marijuana use trajectories / ChienTi PLUMMER LEE in Development and Psychopathology, 34-1 (February 2022)
[article]
Titre : Childhood polyvictimization and marijuana use trajectories Type de document : Texte imprimé et/ou numérique Auteurs : ChienTi PLUMMER LEE, Auteur ; Joshua MERSKY, Auteur ; Ian MARSEE, Auteur ; Bernard FUEMMELER, Auteur Article en page(s) : p.273-283 Langues : Anglais (eng) Mots-clés : marijuana polyvictimization trauma Add Health Index. décimale : PER Périodiques Résumé : Despite public sentiment to the contrary, recreational marijuana use is deleterious to adolescent health and development. Prospective studies of marijuana use trajectories and their predictors are needed to differentiate risk profiles and inform intervention strategies. Using data on 15,960 participants in the National Longitudinal Study of Adolescent to Adult Health, variable-centered approaches were used to examine the impact of childhood polyvictimization on marijuana onset, marijuana use from age 15 to 24 years, and marijuana dependence symptoms. Zero-Inflated Poisson latent class growth analysis (ZIP-LCGA) was used to identify marijuana use subgroups, and their associations with childhood polyvictimization were tested via multinomial logit regression within ZIP-LCGA. Results showed that the overall probability and frequency of marijuana use increased throughout adolescence, peaked in early adulthood, and diminished gradually thereafter. Polyvictimization was associated with earlier onset and greater overall use, frequency of use, and dependence symptoms. ZIP-LCGA uncovered four subgroups, including non-users and three classes of users: adolescence-limited users, escalators, and chronic users. Polyvictimization distinguished non-users from all classes of marijuana users. The findings underscore the lasting developmental implications of significant childhood trauma. Children who experience polyvictimization represent a group that may benefit from selective interventions aimed at preventing early, frequent, chronic, and dependent marijuana use. En ligne : http://dx.doi.org/10.1017/s0954579420000875 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=474
in Development and Psychopathology > 34-1 (February 2022) . - p.273-283[article] Childhood polyvictimization and marijuana use trajectories [Texte imprimé et/ou numérique] / ChienTi PLUMMER LEE, Auteur ; Joshua MERSKY, Auteur ; Ian MARSEE, Auteur ; Bernard FUEMMELER, Auteur . - p.273-283.
Langues : Anglais (eng)
in Development and Psychopathology > 34-1 (February 2022) . - p.273-283
Mots-clés : marijuana polyvictimization trauma Add Health Index. décimale : PER Périodiques Résumé : Despite public sentiment to the contrary, recreational marijuana use is deleterious to adolescent health and development. Prospective studies of marijuana use trajectories and their predictors are needed to differentiate risk profiles and inform intervention strategies. Using data on 15,960 participants in the National Longitudinal Study of Adolescent to Adult Health, variable-centered approaches were used to examine the impact of childhood polyvictimization on marijuana onset, marijuana use from age 15 to 24 years, and marijuana dependence symptoms. Zero-Inflated Poisson latent class growth analysis (ZIP-LCGA) was used to identify marijuana use subgroups, and their associations with childhood polyvictimization were tested via multinomial logit regression within ZIP-LCGA. Results showed that the overall probability and frequency of marijuana use increased throughout adolescence, peaked in early adulthood, and diminished gradually thereafter. Polyvictimization was associated with earlier onset and greater overall use, frequency of use, and dependence symptoms. ZIP-LCGA uncovered four subgroups, including non-users and three classes of users: adolescence-limited users, escalators, and chronic users. Polyvictimization distinguished non-users from all classes of marijuana users. The findings underscore the lasting developmental implications of significant childhood trauma. Children who experience polyvictimization represent a group that may benefit from selective interventions aimed at preventing early, frequent, chronic, and dependent marijuana use. En ligne : http://dx.doi.org/10.1017/s0954579420000875 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=474 Why now? Examining antecedents for substance use initiation among African American adolescents / Tamika C. B. ZAPOLSKI in Development and Psychopathology, 32-2 (May 2020)
[article]
Titre : Why now? Examining antecedents for substance use initiation among African American adolescents Type de document : Texte imprimé et/ou numérique Auteurs : Tamika C. B. ZAPOLSKI, Auteur ; Tianyi YU, Auteur ; Gene H. BRODY, Auteur ; Devin E. BANKS, Auteur ; Allen W. BARTON, Auteur Article en page(s) : p.719-734 Langues : Anglais (eng) Mots-clés : African Americans adolescence alcohol initiation marijuana tobacco Index. décimale : PER Périodiques Résumé : Current adolescent substance use risk models have inadequately predicted use for African Americans, offering limited knowledge about differential predictability as a function of developmental period. Among a sample of 500 African American youth (ages 11-21), four risk indices (i.e., social risk, attitudinal risk, intrapersonal risk, and racial discrimination risk) were examined in the prediction of alcohol, marijuana, and cigarette initiation during early (ages 11-13), mid (ages 16-18), and late (ages 19-21) adolescence. Results showed that when developmental periods were combined, racial discrimination was the only index that predicted initiation for all three substances. However, when risk models were stratified based on developmental period, variation was found within and across substance types. Results highlight the importance of racial discrimination in understanding substance use initiation among African American youth and the need for tailored interventions based on developmental stage. En ligne : http://dx.doi.org/10.1017/s0954579419000713 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=426
in Development and Psychopathology > 32-2 (May 2020) . - p.719-734[article] Why now? Examining antecedents for substance use initiation among African American adolescents [Texte imprimé et/ou numérique] / Tamika C. B. ZAPOLSKI, Auteur ; Tianyi YU, Auteur ; Gene H. BRODY, Auteur ; Devin E. BANKS, Auteur ; Allen W. BARTON, Auteur . - p.719-734.
Langues : Anglais (eng)
in Development and Psychopathology > 32-2 (May 2020) . - p.719-734
Mots-clés : African Americans adolescence alcohol initiation marijuana tobacco Index. décimale : PER Périodiques Résumé : Current adolescent substance use risk models have inadequately predicted use for African Americans, offering limited knowledge about differential predictability as a function of developmental period. Among a sample of 500 African American youth (ages 11-21), four risk indices (i.e., social risk, attitudinal risk, intrapersonal risk, and racial discrimination risk) were examined in the prediction of alcohol, marijuana, and cigarette initiation during early (ages 11-13), mid (ages 16-18), and late (ages 19-21) adolescence. Results showed that when developmental periods were combined, racial discrimination was the only index that predicted initiation for all three substances. However, when risk models were stratified based on developmental period, variation was found within and across substance types. Results highlight the importance of racial discrimination in understanding substance use initiation among African American youth and the need for tailored interventions based on developmental stage. En ligne : http://dx.doi.org/10.1017/s0954579419000713 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=426 Annual Research Review: On the developmental neuropsychology of substance use disorders / Patricia J. CONROD in Journal of Child Psychology and Psychiatry, 57-3 (March 2016)
[article]
Titre : Annual Research Review: On the developmental neuropsychology of substance use disorders Type de document : Texte imprimé et/ou numérique Auteurs : Patricia J. CONROD, Auteur ; Kyriaki NIKOLAOU, Auteur Article en page(s) : p.371-394 Langues : Anglais (eng) Mots-clés : Substance use substance dependence brain development adolescence reward processing executive control cognitive control behavioural inhibition fMRI alcohol marijuana cigarette use Index. décimale : PER Périodiques Résumé : Background Adolescence represents a period of development during which critical biological, as well as social and cognitive, changes occur that are necessary for the transition into adulthood. A number of researchers have suggested that the pattern of normative brain changes that occurs during this period not only predisposes adolescents to engage in risk behaviours, such as experimentation with drugs, but that they additionally make the adolescent brain more vulnerable to the direct pharmacological impact of substances of abuse. The neural circuits that we examine in this review involve cortico-basal-ganglia/limbic networks implicated in the processing of rewards, emotion regulation, and the control of behaviour, emotion and cognition. Findings and Conclusions We identify certain neurocognitive and personality/comorbidity-based risk factors for the onset of substance misuse during adolescence, and summarise the evidence suggesting that these risk factors may be further impacted by the direct effect of drugs on the underlying neural circuits implicated in substance misuse vulnerability. En ligne : http://dx.doi.org/10.1111/jcpp.12516 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=282
in Journal of Child Psychology and Psychiatry > 57-3 (March 2016) . - p.371-394[article] Annual Research Review: On the developmental neuropsychology of substance use disorders [Texte imprimé et/ou numérique] / Patricia J. CONROD, Auteur ; Kyriaki NIKOLAOU, Auteur . - p.371-394.
Langues : Anglais (eng)
in Journal of Child Psychology and Psychiatry > 57-3 (March 2016) . - p.371-394
Mots-clés : Substance use substance dependence brain development adolescence reward processing executive control cognitive control behavioural inhibition fMRI alcohol marijuana cigarette use Index. décimale : PER Périodiques Résumé : Background Adolescence represents a period of development during which critical biological, as well as social and cognitive, changes occur that are necessary for the transition into adulthood. A number of researchers have suggested that the pattern of normative brain changes that occurs during this period not only predisposes adolescents to engage in risk behaviours, such as experimentation with drugs, but that they additionally make the adolescent brain more vulnerable to the direct pharmacological impact of substances of abuse. The neural circuits that we examine in this review involve cortico-basal-ganglia/limbic networks implicated in the processing of rewards, emotion regulation, and the control of behaviour, emotion and cognition. Findings and Conclusions We identify certain neurocognitive and personality/comorbidity-based risk factors for the onset of substance misuse during adolescence, and summarise the evidence suggesting that these risk factors may be further impacted by the direct effect of drugs on the underlying neural circuits implicated in substance misuse vulnerability. En ligne : http://dx.doi.org/10.1111/jcpp.12516 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=282 A natural history study of medical cannabis consumption in pediatric autism in the United States / Mary Ann DILIBERTO in Research in Autism Spectrum Disorders, 96 (August 2022)
[article]
Titre : A natural history study of medical cannabis consumption in pediatric autism in the United States Type de document : Texte imprimé et/ou numérique Auteurs : Mary Ann DILIBERTO, Auteur ; Athena F. ZUPPA, Auteur ; Amanda CORNETTA, Auteur ; Walter FAIG, Auteur ; Tryce SCULLY, Auteur ; Amanda BENNETT, Auteur ; Meghan THOMAS, Auteur ; Elizabeth WARD, Auteur ; Stephen BARR, Auteur ; Benjamin E. YERYS, Auteur Article en page(s) : 101994 Langues : Anglais (eng) Mots-clés : Marijuana Treatment Alternative medicine Children Youth Index. décimale : PER Périodiques Résumé : Background Autism spectrum disorder is specifically approved for medical cannabis consumption in 20 U.S. states, the District of Columbia, and the Territory of Puerto Rico. Despite increased access, there is limited knowledge about who consumes medical cannabis, what they consume, and perceived effectiveness. We addressed these gaps by conducting a natural history study of medical cannabis consumption. Method Children and their families engaged with a large pediatric care system were recruited to complete a telephonic study regarding their medical cannabis consumption. All children had to be consuming approved medical cannabis products issued from a state that had legalized medical cannabis for the treatment of ASD or related behaviors (irritability, hyperactivity, anxiety) (N = 89). Results The sample?s ?level of support? and gender-ratio reflected the general autism population (~33 % requiring ?Very Substantial Support? and ~80 % male). The most common treatment targets were ASD behaviors (repetitive behaviors) and irritability. More children consumed compounds with high cannabidiol (CBD) and low or no tetrahydrocannabinol (THC). While dose did not affect overall perceived effectiveness, compounds with high-levels of CBD and low-levels of THC (CBD-dominant) were perceived as more effective than CBD-only. Conclusions This ?real world? study revealed that medical cannabis is being used to treat a wide range of behaviors. Our study also suggests that children consume CBD-rich products, and the effectiveness of CBD-dosing may be tied to the inclusion of THC in the compound. Future research should evaluate optimal dosing with a particular focus on the CBD-to-THC ratio. En ligne : https://doi.org/10.1016/j.rasd.2022.101994 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=480
in Research in Autism Spectrum Disorders > 96 (August 2022) . - 101994[article] A natural history study of medical cannabis consumption in pediatric autism in the United States [Texte imprimé et/ou numérique] / Mary Ann DILIBERTO, Auteur ; Athena F. ZUPPA, Auteur ; Amanda CORNETTA, Auteur ; Walter FAIG, Auteur ; Tryce SCULLY, Auteur ; Amanda BENNETT, Auteur ; Meghan THOMAS, Auteur ; Elizabeth WARD, Auteur ; Stephen BARR, Auteur ; Benjamin E. YERYS, Auteur . - 101994.
Langues : Anglais (eng)
in Research in Autism Spectrum Disorders > 96 (August 2022) . - 101994
Mots-clés : Marijuana Treatment Alternative medicine Children Youth Index. décimale : PER Périodiques Résumé : Background Autism spectrum disorder is specifically approved for medical cannabis consumption in 20 U.S. states, the District of Columbia, and the Territory of Puerto Rico. Despite increased access, there is limited knowledge about who consumes medical cannabis, what they consume, and perceived effectiveness. We addressed these gaps by conducting a natural history study of medical cannabis consumption. Method Children and their families engaged with a large pediatric care system were recruited to complete a telephonic study regarding their medical cannabis consumption. All children had to be consuming approved medical cannabis products issued from a state that had legalized medical cannabis for the treatment of ASD or related behaviors (irritability, hyperactivity, anxiety) (N = 89). Results The sample?s ?level of support? and gender-ratio reflected the general autism population (~33 % requiring ?Very Substantial Support? and ~80 % male). The most common treatment targets were ASD behaviors (repetitive behaviors) and irritability. More children consumed compounds with high cannabidiol (CBD) and low or no tetrahydrocannabinol (THC). While dose did not affect overall perceived effectiveness, compounds with high-levels of CBD and low-levels of THC (CBD-dominant) were perceived as more effective than CBD-only. Conclusions This ?real world? study revealed that medical cannabis is being used to treat a wide range of behaviors. Our study also suggests that children consume CBD-rich products, and the effectiveness of CBD-dosing may be tied to the inclusion of THC in the compound. Future research should evaluate optimal dosing with a particular focus on the CBD-to-THC ratio. En ligne : https://doi.org/10.1016/j.rasd.2022.101994 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=480 Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development / Carolyn G. DIGUISEPPI in Journal of Autism and Developmental Disorders, 52-11 (November 2022)
[article]
Titre : Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development Type de document : Texte imprimé et/ou numérique Auteurs : Carolyn G. DIGUISEPPI, Auteur ; Tessa CRUME, Auteur ; Julia VAN DYKE, Auteur ; Katherine R. SABOURIN, Auteur ; Gnakub N. SOKE, Auteur ; Lisa A. CROEN, Auteur ; Julie L. DANIELS, Auteur ; Li-Ching LEE, Auteur ; Laura A. SCHIEVE, Auteur ; Gayle C. WINDHAM, Auteur ; Sandra FRIEDMAN, Auteur ; Cordelia ROBINSON ROSENBERG, Auteur Article en page(s) : p.5064-5071 Langues : Anglais (eng) Mots-clés : Autism Spectrum Disorder/epidemiology Cannabis/adverse effects Case-Control Studies Female Humans Pregnancy Autism spectrum disorder Cannabis Epidemiology Marijuana interest. Index. décimale : PER Périodiques Résumé : The association of autism spectrum disorder (ASD) with self-reported maternal cannabis use from 3Â months pre-conception to delivery ("peri-pregnancy") was assessed in children aged 30-68Â months, born 2003 to 2011. Children with ASD (N=1428) were compared to children with other developmental delays/disorders (DD, N=1198) and population controls (POP, N=1628). Peri-pregnancy cannabis use was reported for 5.2% of ASD, 3.2% of DD and 4.4% of POP children. Adjusted odds of peri-pregnancy cannabis use did not differ significantly between ASD cases and DD or POP controls. Results were similar for any use during pregnancy. However, given potential risks suggested by underlying neurobiology and animal models, further studies in more recent cohorts, in which cannabis use and perception may have changed, are needed. En ligne : http://dx.doi.org/10.1007/s10803-021-05339-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=489
in Journal of Autism and Developmental Disorders > 52-11 (November 2022) . - p.5064-5071[article] Peri-Pregnancy Cannabis Use and Autism Spectrum Disorder in the Offspring: Findings from the Study to Explore Early Development [Texte imprimé et/ou numérique] / Carolyn G. DIGUISEPPI, Auteur ; Tessa CRUME, Auteur ; Julia VAN DYKE, Auteur ; Katherine R. SABOURIN, Auteur ; Gnakub N. SOKE, Auteur ; Lisa A. CROEN, Auteur ; Julie L. DANIELS, Auteur ; Li-Ching LEE, Auteur ; Laura A. SCHIEVE, Auteur ; Gayle C. WINDHAM, Auteur ; Sandra FRIEDMAN, Auteur ; Cordelia ROBINSON ROSENBERG, Auteur . - p.5064-5071.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 52-11 (November 2022) . - p.5064-5071
Mots-clés : Autism Spectrum Disorder/epidemiology Cannabis/adverse effects Case-Control Studies Female Humans Pregnancy Autism spectrum disorder Cannabis Epidemiology Marijuana interest. Index. décimale : PER Périodiques Résumé : The association of autism spectrum disorder (ASD) with self-reported maternal cannabis use from 3Â months pre-conception to delivery ("peri-pregnancy") was assessed in children aged 30-68Â months, born 2003 to 2011. Children with ASD (N=1428) were compared to children with other developmental delays/disorders (DD, N=1198) and population controls (POP, N=1628). Peri-pregnancy cannabis use was reported for 5.2% of ASD, 3.2% of DD and 4.4% of POP children. Adjusted odds of peri-pregnancy cannabis use did not differ significantly between ASD cases and DD or POP controls. Results were similar for any use during pregnancy. However, given potential risks suggested by underlying neurobiology and animal models, further studies in more recent cohorts, in which cannabis use and perception may have changed, are needed. En ligne : http://dx.doi.org/10.1007/s10803-021-05339-4 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=489